Barbara Kosacz Kronos Bio, Inc. (KRON) insider trading activity

Barbara Kosacz is COO & General Counsel of Kronos Bio, Inc.. Currently has a direct ownership of 928,966 shares of KRON, which is worth approximately $891,807. The most recent transaction as insider was on Jan 04, 2024, when has been sold 10,676 shares (Common Stock) at a price of $1.18 per share, resulting in proceeds of $12,597. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 929K

0% 3M change

1.14% 12M change

Total Value Held $891,807

Barbara Kosacz Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 04 2024	SELL Open market or private sale	$12,597 $1.18 p/Share	10,676 Reduced 1.14%	928,966 Common Stock
Feb 15 2023	BUY Grant, award, or other acquisition	-	138,911 Added 12.88%	939,642 Common Stock
Jul 25 2022	BUY Grant, award, or other acquisition	-	53,600 Added 6.34%	791,624 Common Stock
Feb 15 2022	BUY Grant, award, or other acquisition	-	53,600 Added 6.77%	738,024 Common Stock
Dec 09 2020	BUY Grant, award, or other acquisition	-	69,824 Added 9.26%	684,424 Common Stock
Oct 14 2020	BUY Open market or private purchase	$99,750 $19.0 p/Share	5,250 Added 0.85%	614,600 Common Stock

Also insider at

EFTR

eFFECTOR Therapeutics, Inc. Healthcare

Director

ATHA

Athira Pharma, Inc. Healthcare

XOMA

XOMA Corp Healthcare

PBAXU

PHOENIX BIOTECH ACQUISITION CORP. Financial Services

Director

Barbara Kosacz

COO & General Counsel

Philadelphia, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRON shares.

Notify only if

Value

Insider Trading

Get notified when an Kronos Bio, Inc. insider buys or sells KRON shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kronos Bio, Inc.

Track Activities on KRON

Account